This Plain Language Summary of Publication article (PLSP) from Neurodegenerative Disease Management, analysed insurance claims from over 8,000 U.S. adults with multiple sclerosis (2011-2017) showed that patients who didn’t take medications as prescribed experienced more frequent relapses, faster progression to needing mobility aids, and higher healthcare costs compared to medication-adherent patients, demonstrating the significant impact of treatment adherence on both health outcomes and medical expenses.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Impact of adherence to disease modifying therapies on long-term clinical and economic outcomes in multiple sclerosis: A claims analysis of real-world data’ and was published in Multiple Sclerosis and Related Disorders.

Visit MSRD using the link to read the original article.